Invention Grant
- Patent Title: Substituted morpholine compounds for the treatment of central nervous system disorders
- Patent Title (中): 用于治疗中枢神经系统疾病的取代吗啉化合物
-
Application No.: US11119210Application Date: 2005-04-29
-
Publication No.: US07659394B2Publication Date: 2010-02-09
- Inventor: Nancy S. Barta , Shelly Ann Glase , David L. Gray , Gregory A. Reichard , Lloyd Jerome Simons , Wenijan Xu
- Applicant: Nancy S. Barta , Shelly Ann Glase , David L. Gray , Gregory A. Reichard , Lloyd Jerome Simons , Wenijan Xu
- Applicant Address: US NY New York
- Assignee: Pfizer Inc
- Current Assignee: Pfizer Inc
- Current Assignee Address: US NY New York
- Agent Gregg C. Benson; James T. Jones
- Main IPC: C07D295/04
- IPC: C07D295/04 ; C07D213/10
Abstract:
This invention relates to compounds of the formulae I wherein R1-R8, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
Public/Granted literature
- US20050245519A1 Substituted morpholine compounds for the treatment of central nervous system disorders Public/Granted day:2005-11-03
Information query
